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Abstract 
Photodynamic therapy(PDT) is a new non-invasive treatment for cancer. PDT 
has many unique advantages compared with traditional cancer treatment. PDT 
initiates a series of biochemical reactions by using appropriate wavelength of light to 
excite photosensitizers in the tissue, leads to cell apoptosis or death. However, most of 
photosensitizers are hydrophobic compounds with low stability in physiological 
conditons, and easily aggtegated in water which would reduce their PDT efficiency. In 
this article, photosensitizers were coupled with molecular umbrella to prevent 
aggregating of photosensitizers by the shielding effect of mulecular umbrella. In 
addition,  amphipathic of molecular umbrella could enhance solubility of 
photosensitizers in water. The main research contents are as follows: 
(1) Synthesis and characterization of zinc(II) phthalocyanine-molecular 
umbrella and tetraphenylporphyrin-molecular umbrella conjugate compounds: the 
synthesis of zinc(II) 4-carboxylphthalocyanine and 
5-(4-carboxylphenyl)-10,15,20-triphenylporphyrin were using probability method. 
The synthesis of zinc(II) 4-carboxylphthalocyanine used phthalic anhydride, 
1,2,4-benzenetricarboxylic anhydride and zinc acetate as raw materials. The synthesis 
of 5-(4-carboxylphenyl)-10,15,20-triphenylporphyrin used pyrrole, benzaldehyde and 
methy 4-formylbenzoate as raw materials. The synthesis of 
N1,N3-dicholeamidospermidine(di-wall molecular umbrella) used cholic acid and 
spermidine as raw materials. The synthesis of zinc(II) phthalocyanine-molecular 
umbrella conjugate compound used zinc(II) 4-carboxylphthalocyanine and 
N1,N3-dicholeamidospermidine as raw materials. The synthesis of 
tetraphenylporphyrin-molecular umbrella conjugate compound used 
5-(4-carboxylphenyl)-10,15,20-triphenylporphyrin and 
N1,N3-dicholeamidospermidine as raw materials. The FTIR, UV-Vis absorption 
spectrum, MALDI-TOF-MS and 1H NMR were used to characterize the structure of 
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(2) Characterization of photodynamic therapy activity of zinc(II) 
phthalocyanine-molecular umbrella and tetraphenylporphyrin-molecular umbrella 
conjugate compounds: all the results got by compared zinc(II) 
phthalocyanine-molecular umbrella and tetraphenylporphyrin-molecular umbrella 
with zinc(II) 4-carboxylphthalocyanine and 
5-(4-carboxylphenyl)-10,15,20-triphenylporphyrin respectively. The different UV-Vis 
absorbance of the same molarity of compounds in different methanol/water ratio of 
mixed solvent indicated that photosensitizer-molecular umbrella conjugate 
compounds got a higher solubility in polar solvent. The different UV-Vis absorbance 
and fluorescence emission spectrum in methanol indicated that 
photosensitizer-molecular umbrella conjugate compounds could prevent 
photosensitizers aggregating. Photostability test indicated photosensitizer-molecular 
umbrella conjugate compounds had good photostability. Singlet oxygen test using 
1,3-diphenylisobenzofuran as indicator indicated photosensitizer-molecular umbrella 
conjugate compounds could improve singlet oxygen yields. 
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- V - 
目录 
摘要......................................................................................................... I 
Abstract ............................................................................................... III 
目录........................................................................................................ V 
Contents.............................................................................................. VII 
第一章 绪论 ...........................................................................................1 
1.1 光动力治疗的研究现状............................................................................... 1 
1.1.1 光动力治疗简介................................................................................. 1 
1.1.2 光动力治疗原理................................................................................. 2 
1.1.3 光动力治疗药物................................................................................. 7 
1.2 分子伞载体的研究现状............................................................................... 9 
1.2.1 分子伞载体简介................................................................................. 9 
1.2.2 分子伞内化机理................................................................................11 
1.2.3 分子伞的应用................................................................................... 14 
1.3 本课题的提出 ............................................................................................ 15 
参考文献........................................................................................................... 16 
第二章 两种单羧基取代光敏剂的合成与表征 .................................. 21 
2.1 引言............................................................................................................. 21 
2.2 实验试剂与仪器 ........................................................................................ 23 
2.3 合成方法与表征方法................................................................................. 24 
2.3.1 4-羧基酞菁锌的合成方法与表征方法.............................................. 24 
2.3.2 5-(4-羧基苯基)-10,15,20-三苯基卟啉的合成方法与表征方法......... 26 














- VI - 
2.4.1 4-羧基酞菁锌 .................................................................................... 28 
2.4.2 5-(4-羧基苯基)-10,15,20-三苯基卟啉 ............................................... 33 
2.5 本章小结 .................................................................................................... 38 
参考文献........................................................................................................... 40 
第三章 分子伞的合成及其与单羧基取代光敏剂的偶联和表征 ....... 42 
3.1 引言............................................................................................................ 42 
3.2 实验试剂与仪器 ........................................................................................ 42 
3.3 分子伞的合成与表征................................................................................. 44 
3.3.1 合成方法与表征方法 ....................................................................... 44 
3.3.2 结果与讨论 ...................................................................................... 46 
3.4 分子伞与单羧基取代光敏剂的偶联与表征.............................................. 50 
3.4.1 偶联反应与表征方法 ....................................................................... 50 
3.4.2 结果与讨论 ...................................................................................... 55 
3.5 本章小结 .................................................................................................... 72 
参考文献........................................................................................................... 73 
第四章 全文结论与展望 ..................................................................... 75 
4.1 引言............................................................................................................ 75 
4.2 全文结论 .................................................................................................... 75 
















- VII - 
Contents 
Abstract in Chinese................................................................................ I 
Abstract in English ............................................................................. III 
Contents in Chinese .............................................................................. V 
Contents in English............................................................................VII 
Chapter 1 Introduction..........................................................................1 
1.1 Photodynamic therapy research present situation ..................................... 1 
1.1.1 Brief introduction of photodynamic therapy ......................................... 1 
1.1.2 Mechanism of photodynamic therapy ................................................... 2 
1.1.3 Medicines of photodynamic therapy..................................................... 7 
1.2 Molecular umbrella research present situation.......................................... 9 
1.2.1 Brief introduction of molecular umbrella.............................................. 9 
1.2.2 Internalization mechanism of molecular umbrella................................11 
1.2.3 Application of molecular umbrella...................................................... 14 
1.3 Purpose and contents................................................................................. 15 
References ........................................................................................................ 16 
Chapter 2 Synthesis and characterization of two mono-carboxyl 
replaced photosensitizers..................................................................... 21 
2.1 Introduction ............................................................................................... 21 
2.2 Experiment reagents and Instruments...................................................... 23 
2.3 Synthesis and characterization methods................................................... 24 
2.3.1 zinc(II) 4-carboxylphthalocyanine ...................................................... 24 
2.3.2 5-(4-carboxylphenyl)-10,15,20-triphenylporphyrin............................. 26 














- VIII - 
2.4.1 zinc(II) 4-carboxylphthalocyanine ...................................................... 28 
2.4.2 5-(4-carboxylphenyl)-10,15,20-triphenylporphyrin............................. 33 
2.5 Summary .................................................................................................... 38 
References ........................................................................................................ 40 
Chapter 3 Synthesis and characterization of molecular umbrella and 
its coupling with mono-carboxyl replaced photosensitizers .............. 42 
3.1 Introduction ............................................................................................... 42 
3.2 Experiment reagents and Instruments...................................................... 42 
3.3 Synthesis and characterization of molecular umbrella ............................ 44 
3.3.1 Methods of synthesis and characterization.......................................... 44 
3.3.2 Results and discussion........................................................................ 46 
3.4 Coupling and characterization of molecular umbrella and mono-carboxyl 
replaced photosensitizers................................................................................. 50 
3.4.1 Methods of coupling and characterization........................................... 50 
3.4.2 Results and discussion........................................................................ 55 
3.5 Summary .................................................................................................... 72 
References ........................................................................................................ 73 
Chapter 4 Conclusions and expectations ............................................ 75 
4.1 Introduction ............................................................................................... 75 
4.2 Conclusions ................................................................................................ 75 
4.3 Expectations ............................................................................................... 76 
Publications .......................................................................................... 77 

































图 1-1 PDT 治疗的原理图[3] 

























日光浴室中进行日光浴。20 世纪，瑞士医生 Bernhard 和 Rollier 重新提出日光疗
法，倡导用日光治疗结核。在古代印度，也曾用 Psoraleacorylifolia 的萃取物(含
呋喃并香豆素)口服后光照治疗白癜风[9]。1897 年德国慕尼黑 Ludwig-Maximilians
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图 1-2 光敏剂的光物理化学机制[12] 













ISC、VR 和 IC 得到的第一激发三重态(T1)的量子产率可以达到 0.7-0.9。第一激
发三重态的存活时间比第一激发单重态长很多，在无氧溶液中，如果不被淬灭，
可以存在 10-4-10-3 s。T1 态的存在时间很长使它成为很多化学反应的起点，这些
反应过程分为两种情况：Type I 和 Type II 反应。在 I 型反应中，光敏剂将能量传
递给周围的生物分子，使其被激发形成自由基，该过程中，氧气可能参与第二步
反应结合到自由基中，形成活性氧自由基，也可能被光敏剂自由基负离子变成超
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